TrialBMJ open2020

Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study.

Faysal Dane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.